Expected earnings - Cue Biopharma Inc.
Source: US Earnings Reports
Cue Biopharma Inc. (CUE) is expected to report $-0.13 for Q2 2025
Cue Biopharma Inc.
NASDAQ: CUE
CUE Trading
8.19% G/L:
$0.3396 Last:
724,837 Volume:
$0.348 Open:
CUE Latest News
March 09, 2026 08:00:00 am
Cue Biopharma to Present New In vitro Data for CUE-401 at the 20th World Immune Regulation Meeting (WIRM) 2026
February 17, 2026 08:00:00 am
Cue Biopharma Announces Preclinical Safety and Tolerability Data for CUE-401 for the Treatment of Autoimmune and Inflammatory Diseases
February 12, 2026 08:00:00 am
Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Financial and Business Officer
CUE Stock Data
$30,117,989
80,549,371
0.16%
23
N/A
Biotechnology & Life Sciences
Healthcare
US
Boston
